Published in Biochem J on August 01, 1982
Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem (1969) 43.83
Superoxide dismutase from escherichia coli B. A new manganese-containing enzyme. J Biol Chem (1970) 5.10
Mechanism of the prolyl hydroxylase reaction. 1. Role of co-substrates. Eur J Biochem (1977) 1.83
The role of ascorbate in the prolyl hydroxylase reaction. Biochem Biophys Res Commun (1978) 1.45
Indoleamine 2,3-dioxygenase. Potassium superoxide as substrate. J Biol Chem (1977) 1.10
Hydroxylation of gamma-butyrobetaine to carnitine in rat liver. Biochemistry (1967) 1.08
Superoxide dismutase activity of low molecular weight Cu2 plus-chelates studied by pulse radiolysis. FEBS Lett (1974) 1.07
Lysyl hydroxylase. Further purification and characterization of the enzyme from chick embryos and chick embryo cartilage. Biochim Biophys Acta (1976) 1.06
Properties of 2-nitropropane dioxygenase of Hansenula mrakii. Formation and participation of superoxide. J Biol Chem (1978) 0.97
Mechanism of superoxide anion scavenging reaction by bis-(salicylato)-copper (II) complex. Biochem Biophys Res Commun (1976) 0.96
Indoleamine 2,3-dioxygenase. Kinetic studies on the binding of superoxide anion and molecular oxygen to enzyme. J Biol Chem (1979) 0.94
18-O studies of the 2-ketoglutarate-dependent sequential oxygenation of thymine to 5-carboxyuracil. J Biol Chem (1971) 0.91
7-Hydroxylation of thymine in a Neurospora strain coupled to oxidative decarboxylation of 2-ketoglutarate. Biochim Biophys Acta (1970) 0.91
Involvement of superoxide in the prolyl and lysyl hydroxylase reactions. Biochem Biophys Res Commun (1979) 0.90
Evidence for free radical involvement in the hydroxylation of proline: inhibition by nitro blue tetrazolium. FEBS Lett (1972) 0.89
Inhibition of lysyl hydroxylase by catechol analogs. Biochim Biophys Acta (1977) 0.83
Thymidine 2'-hydroxylation in Neurospora crassa. J Biol Chem (1972) 0.83
Purification and properties of gamma-butyrobetaine hydroxylase from Pseudomonas sp AK 1. Biochemistry (1977) 0.82
Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet (1992) 4.23
On the enzymic defects in hereditary tyrosinemia. Proc Natl Acad Sci U S A (1977) 3.18
Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I. Nat Genet (1995) 2.62
Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet (1989) 2.54
Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr Res (1990) 2.47
Superoxide dismutase in extracellular fluids. Clin Chim Acta (1982) 2.32
Mitochondrial encephalomyopathies in childhood. I. Biochemical and morphologic investigations. J Pediatr (1991) 2.04
A method for the determination of carnitine in the picomole range. Clin Chim Acta (1972) 1.97
Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione). J Inherit Metab Dis (1998) 1.97
Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings. Eur Heart J (2003) 1.95
Clinical significance of low serum thyrotropin concentration by chemiluminometric assay in 85-year-old women and men. Arch Intern Med (1991) 1.91
Polycyclic aromatic hydrocarbons in the occupational environment: with special reference to benzo[a]pyrene measurements in Swedish industry. Scand J Work Environ Health (1982) 1.83
Swedish obese subjects (SOS)--an intervention study of obesity. Baseline evaluation of health and psychosocial functioning in the first 1743 subjects examined. Int J Obes Relat Metab Disord (1993) 1.75
Segregation and manifestations of the mtDNA tRNA(Lys) A-->G(8344) mutation of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am J Hum Genet (1992) 1.73
Clonal expansion of mitochondrial DNA with multiple deletions in autosomal dominant progressive external ophthalmoplegia. Ann Neurol (1996) 1.69
The population study of women in Göteborg 1974--1975--the second phase of a longitudinal study. General design, purpose and sampling results. Scand J Soc Med (1978) 1.69
Screening for thyroid disease in a primary care unit with a thyroid stimulating hormone assay with a low detection limit. BMJ (1988) 1.68
A rapid method for the determination of mercury in urine. Analyst (1970) 1.67
Humoral and cellular immune responses up to 7.5 years after administration of streptokinase for acute myocardial infarction. Eur Heart J (1999) 1.64
Low levels of mitochondrial transcription factor A in mitochondrial DNA depletion. Biochem Biophys Res Commun (1994) 1.63
The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord (1992) 1.61
Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res (1992) 1.56
Morbidity, mortality, and quality of life for patients treated with levothyroxine. Arch Intern Med (1990) 1.54
The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA anbormalities. Ann Neurol (2001) 1.53
Recurrent metabolic decompensation in profound carnitine palmitoyltransferase II deficiency. J Pediatr (1993) 1.52
Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism. Surgery (1991) 1.51
Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency. Hum Genet (1999) 1.48
Leber's hereditary optic neuropathy and complex I deficiency in muscle. Ann Neurol (1991) 1.46
Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab (1993) 1.45
Smoking--a risk factor for hypothyroidism. J Endocrinol Invest (1993) 1.45
Automatic sequencing of mitochondrial tRNA genes in patients with mitochondrial encephalomyopathy. Biochim Biophys Acta (1994) 1.44
IgA class anticardiolipin antibodies in cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol (1996) 1.40
[Para-malignant phenomena in liver cancer]. Lakartidningen (1990) 1.39
The population study of women in Gothenburg 1980-81--the third phase of a longitudinal study. Comparison between participants and non-participants. Scand J Soc Med (1989) 1.38
[Bone marrow depression after azathioprine. New discoveries on an old drug]. Lakartidningen (2000) 1.38
Effects of electro-acupuncture on anovulation in women with polycystic ovary syndrome. Acta Obstet Gynecol Scand (2000) 1.37
The effect of dietary fat on the turnover of cholic acid and on the composition of the biliary bile acids in man. J Clin Invest (1965) 1.36
A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism. Clin Endocrinol (Oxf) (1988) 1.33
Simultaneous A8344G heteroplasmy and mitochondrial DNA copy number quantification in myoclonus epilepsy and ragged-red fibers (MERRF) syndrome by a multiplex molecular beacon based real-time fluorescence PCR. Nucleic Acids Res (2001) 1.30
Screening for iron deficiency: an analysis based on bone-marrow examinations and serum ferritin determinations in a population sample of women. Br J Haematol (1993) 1.30
Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol (Oxf) (1994) 1.29
The mechanism of enzymic formation of homogentisate from p-hydroxyphenylpyruvate. J Am Chem Soc (1970) 1.28
Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril (1992) 1.26
Hemostatic and metabolic variables in women with polycystic ovary syndrome. Fertil Steril (1994) 1.22
Dietary treatment in tyrosinemia (tyrosinosis). With a note on the possible recognition of the carrier state. Am J Dis Child (1967) 1.18
Purification and some properties of human 4-hydroxyphenylpyruvate dioxygenase (I). J Biol Chem (1977) 1.15
Prevalence of iron deficiency in Swedish adolescents. Pediatr Res (1993) 1.13
On the prevalence, diagnosis and management of lithium-induced hypothyroidism in psychiatric patients. Br J Psychiatry (1977) 1.12
Characterization of 4-hydroxyphenylpyruvate dioxygenase. Primary structure of the Pseudomonas enzyme. Eur J Biochem (1992) 1.11
A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators. Proc Natl Acad Sci U S A (1997) 1.10
Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus. Clin Exp Immunol (1986) 1.09
Hydroxylation of gamma-butyrobetaine to carnitine in rat liver. Biochemistry (1967) 1.08
Purification and some properties of 4-hydroxyphenylpyruvate dioxygenase from Pseudomonas sp. P. J. 874. Biochemistry (1977) 1.07
Alcoholics with reduced dopamine D2 receptor function possess normal platelet monoamine oxidase activity. Alcohol Alcohol (1994) 1.07
Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy. Acta Paediatr (2004) 1.07
Metabolism of 2-amino-5-hydroxyadipic acid in the rat. Arch Biochem Biophys (1967) 1.05
Decreased aminoacylation of mutant tRNAs in MELAS but not in MERRF patients. Hum Mol Genet (2000) 1.05
Low concentrations of insulin-like growth factor-I in abdominal obesity. Int J Obes Relat Metab Disord (1993) 1.04
Mitochondrial ATP-synthase deficiency in a child with 3-methylglutaconic aciduria. Pediatr Res (1992) 1.03
Possibilities for treatment and for early prenatal diagnosis of hereditary tyrosinaemia. Lancet (1985) 1.03
Human 4-hydroxyphenylpyruvate dioxygenase. Primary structure and chromosomal localization of the gene. Eur J Biochem (1993) 1.02
Mitochondrial DNA deletions and cytochrome c oxidase deficiency in muscle fibres. J Neurol Sci (1992) 1.01
Thyroid disease in middle-aged and elderly Swedish women: thyroid-related hormones, thyroid dysfunction and goitre in relation to age and smoking. J Intern Med (1991) 1.01
Causes of malabsorption after total gastrectomy with Roux-en-Y reconstruction. Acta Chir Scand (1988) 1.01
Prevention of immune precipitation by purified components of the alternative pathway. Clin Exp Immunol (1985) 1.00
Mitochondrial DNA deletions in muscle fibers in inclusion body myositis. J Neuropathol Exp Neurol (1995) 1.00
On metabolic effects of diuretics and beta-blockers. Results from a cross-sectional and longitudinal population study of women. Acta Med Scand (1982) 1.00
Osteoporosis, metabolic aberrations, and increased risk for vertebral fractures after partial gastrectomy. Calcif Tissue Int (1993) 1.00
Plasma enteroglucagon related to malabsorption in coeliac disease. Gut (1984) 0.99
Exertion of delta-aminolevulinic acid in hereditary tyrosinemia. Clin Chim Acta (1969) 0.99
Somatostatin receptor scintigraphy in medullary thyroid carcinoma. Br J Surg (1997) 0.99
Mitochondrial DNA deletions in inclusion body myositis. Brain (1993) 0.99
Overweight--a common problem among women treated for hyperthyroidism. Postgrad Med J (1993) 0.99
Minor signs and symptoms of toxicity in a young woman in spite of massive thyroxine ingestion. Acta Med Scand (1980) 0.98
Sunlight increases serum 25(OH) vitamin D concentration whereas 1,25(OH)2D3 is unaffected. Results from a general population study in Göteborg, Sweden (The WHO MONICA Project). Eur J Clin Nutr (1995) 0.98
Monoclonal IgG cryoglobulinemia with secondary development of glomerulonephritis and nephrotic syndrome. Q J Med (1975) 0.97
Purification of p-hydroxyphenylpyruvate hydroxylase from human liver. Acta Chem Scand (1970) 0.97
Familial protein intolerance. Possible nature of enzyme defect. N Engl J Med (1971) 0.96
Deficiency of mitochondrial ATP synthase of nuclear genetic origin. Neuromuscul Disord (2006) 0.96
Adrenocortical carcinoma: surgery and mitotane for treatment and steroid profiles for follow-up. World J Surg (1998) 0.96
Renal medullary cystic disease or familial juvenile nephronophthisis: a renal tubular disease. Biochemical findings in two siblings. Am J Med (1970) 0.96
Neonatal screen for hereditary tyrosinaemia type I. Lancet (1992) 0.96
Nontransplant treatment of tyrosinemia. Clin Liver Dis (2000) 0.95
Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology (1995) 0.95
Effect of long-term oral testosterone undecanoate treatment on prostate volume and serum prostate-specific antigen concentration in eugonadal middle-aged men. Prostate (1993) 0.95
Ophthalmological findings in children and young adults with genetically verified mitochondrial disease. Br J Ophthalmol (2010) 0.94
A kinetic study of thymine 7-hydroxylase from neurospora crassa. Biochemistry (1975) 0.94
Erosive oral lichen planus and salivary cortisol. J Oral Pathol Med (2001) 0.94
Dexamethasone suppression test and serum prolactin in dementia disorders. Br J Psychiatry (1983) 0.94
Diagnosis and management of tyrosinemia type I. Curr Opin Pediatr (1995) 0.93
Lack of transmission of deleted mtDNA from a woman with Kearns-Sayre syndrome to her child. Am J Hum Genet (1992) 0.93
Cofactor requirements of gamma-butyrobetaine hydroxylase from rat liver. J Biol Chem (1970) 0.93